Relationship between CD4+ T‐cell counts at baseline and initial periodontal treatment efficacy in patients undergoing treatment for HIV infection: A retrospective observational study

Abstract

AbstractAimTo retrospectively investigate the relationship between the CD4+ T‐cell counts at baseline and the efficacy of the initial periodontal treatment of patients undergoing treatment for human immunodeficiency virus (HIV) infection using the periodontal inflamed surface area (PISA).Materials and MethodsThirty‐three patients with chronic periodontitis who had undergone periodontal examination at baseline and after the initial periodontal treatment were enrolled. PISA was calculated from the periodontal probing depth and bleeding on probing, and the ratio of PISA after treatment to that at baseline (PISA response ratio) was calculated. Groups with a response ratio of <1 and ≥1 were defined as the improvement and the non‐improvement groups, respectively.ResultsPISA after the initial periodontal treatment significantly decreased compared with that at baseline (p < .05). A weak negative correlation was found between the PISA response ratio and CD4+ T‐cell counts at baseline (p < .05). The CD4+ T‐cell counts at baseline were significantly higher in the improvement group than in the non‐improvement group (p < .05). Multivariate analysis revealed that the CD4+ T‐cell counts at baseline was an independent factor that affects the PISA (p < .05).ConclusionsThe higher the CD4+ T‐cell counts at baseline in patients undergoing treatment for HIV infection, the more effective the initial periodontal treatment.